Auransa Inc.
6Patents
6Active
6Granted
45Portfolio score
Filing activity: Feb 3, 2017 → Oct 7, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10874633B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 2 | Active |
| US10806716B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 2 | Active |
| US11166936B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 1 | Active |
| US12286622B2 | Genomics-based identification and characterization of rare cell types | Physics | 0 | Active |
| US11485725B2 | Derivatives of piperlongumine and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11786503B2 | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.